135 related articles for article (PubMed ID: 18508621)
1. Cystatin C and cathepsins in cardiovascular disease.
Bengtsson E; Nilsson J; Jovinge S
Front Biosci; 2008 May; 13():5780-6. PubMed ID: 18508621
[TBL] [Abstract][Full Text] [Related]
2. Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases.
Wu H; Du Q; Dai Q; Ge J; Cheng X
J Atheroscler Thromb; 2018 Feb; 25(2):111-123. PubMed ID: 28978867
[TBL] [Abstract][Full Text] [Related]
3. Lysosomal cysteine proteases in atherosclerosis.
Liu J; Sukhova GK; Sun JS; Xu WH; Libby P; Shi GP
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1359-66. PubMed ID: 15178558
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms.
Aoki T; Kataoka H; Ishibashi R; Nozaki K; Hashimoto N
Stroke; 2008 Sep; 39(9):2603-10. PubMed ID: 18635848
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves.
Helske S; Syväranta S; Lindstedt KA; Lappalainen J; Oörni K; Mäyränpää MI; Lommi J; Turto H; Werkkala K; Kupari M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1791-8. PubMed ID: 16728655
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointima of balloon-injured rat carotid arteries.
Cheng XW; Kuzuya M; Sasaki T; Arakawa K; Kanda S; Sumi D; Koike T; Maeda K; Tamaya-Mori N; Shi GP; Saito N; Iguchi A
Am J Pathol; 2004 Jan; 164(1):243-51. PubMed ID: 14695337
[TBL] [Abstract][Full Text] [Related]
7. Role of cathepsins and cystatins in patients with recurrent miscarriage.
Nakanishi T; Ozaki Y; Blomgren K; Tateyama H; Sugiura-Ogasawara M; Suzumori K
Mol Hum Reprod; 2005 May; 11(5):351-5. PubMed ID: 15863450
[TBL] [Abstract][Full Text] [Related]
8. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
[TBL] [Abstract][Full Text] [Related]
9. Increased serum cathepsin S in patients with atherosclerosis and diabetes.
Liu J; Ma L; Yang J; Ren A; Sun Z; Yan G; Sun J; Fu H; Xu W; Hu C; Shi GP
Atherosclerosis; 2006 Jun; 186(2):411-9. PubMed ID: 16140306
[TBL] [Abstract][Full Text] [Related]
10. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation.
Lutgens E; Lutgens SP; Faber BC; Heeneman S; Gijbels MM; de Winther MP; Frederik P; van der Made I; Daugherty A; Sijbers AM; Fisher A; Long CJ; Saftig P; Black D; Daemen MJ; Cleutjens KB
Circulation; 2006 Jan; 113(1):98-107. PubMed ID: 16365196
[TBL] [Abstract][Full Text] [Related]
12. Induced expression of cathepsins and cystatin C in a murine model of demyelination.
Ma J; Tanaka KF; Yamada G; Ikenaka K
Neurochem Res; 2007 Feb; 32(2):311-20. PubMed ID: 17086443
[TBL] [Abstract][Full Text] [Related]
13. Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice.
Bengtsson E; To F; Grubb A; Håkansson K; Wittgren L; Nilsson J; Jovinge S
Atherosclerosis; 2005 May; 180(1):45-53. PubMed ID: 15823274
[TBL] [Abstract][Full Text] [Related]
14. Destabilizing role of cathepsin S in murine atherosclerotic plaques.
Rodgers KJ; Watkins DJ; Miller AL; Chan PY; Karanam S; Brissette WH; Long CJ; Jackson CL
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):851-6. PubMed ID: 16410454
[TBL] [Abstract][Full Text] [Related]
15. Role of cathepsin K in structural changes in brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice.
Samokhin AO; Wong A; Saftig P; Brömme D
Atherosclerosis; 2008 Sep; 200(1):58-68. PubMed ID: 18291403
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory properties of cystatin F and its localization in U937 promonocyte cells.
Langerholc T; Zavasnik-Bergant V; Turk B; Turk V; Abrahamson M; Kos J
FEBS J; 2005 Mar; 272(6):1535-45. PubMed ID: 15752368
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.
Sukhova GK; Zhang Y; Pan JH; Wada Y; Yamamoto T; Naito M; Kodama T; Tsimikas S; Witztum JL; Lu ML; Sakara Y; Chin MT; Libby P; Shi GP
J Clin Invest; 2003 Mar; 111(6):897-906. PubMed ID: 12639996
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin cysteine proteases in cardiovascular disease.
Lutgens SP; Cleutjens KB; Daemen MJ; Heeneman S
FASEB J; 2007 Oct; 21(12):3029-41. PubMed ID: 17522380
[TBL] [Abstract][Full Text] [Related]
19. Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis.
Haves-Zburof D; Paperna T; Gour-Lavie A; Mandel I; Glass-Marmor L; Miller A
J Cell Mol Med; 2011 Nov; 15(11):2421-9. PubMed ID: 21143385
[TBL] [Abstract][Full Text] [Related]
20. Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis.
Morko JP; Söderström M; Säämänen AM; Salminen HJ; Vuorio EI
Ann Rheum Dis; 2004 Jun; 63(6):649-55. PubMed ID: 15140771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
